🔗 Share this article

A shadow economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to message these accounts directly for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with numerous of participants share comparison images, injection guides and claims of rapid British shipping. Sellers promote the drug there before directing buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals administering products of uncertain source.

Several experts said the demand for the experimental drug could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, advertising, and consumer laws, risking penalties, legal action or prison.

Platform Response and Content Removal

Based on TikTok, the service has removed violative material and prohibited related keywords and search suggestions. The company said it was dedicated to maintaining the platform secure and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Investigations also discovered communities with up to nine thousand members selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of users, populated with images of weight loss, positive testimonials and detailed instructions for preparing or injecting at home.

After moments of entering one group, a seller posted contact information, where the majority of purchases occur. The seller provided an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.

Product Information and Pricing

Within these groups, posts display black plastic packages with postal service stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how long a pen should last, sellers give conflicting responses varying between a several days to “depends on your body”.

Platform Oversight and Safety Actions

A representative for Telegram stated it regularly monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering materials they can’t verify. Although the science behind retatrutide is sound, these online products may not include what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has previously seen individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject patients to potentially significant health risks”.